recombinant staphylococcus aureus vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2016 (NCT02804711)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Staphylococcus aureusImmunity, active
immunity, active - staphylococcus aureus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- recombinant staphylococcus aureus vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02804711 | Phase 1 | Sep 1, 2016 | Chengdu Olymvax Biopharmaceuticals Inc., Government of China, People's Liberation Army of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chengdu Olymvax Biopharmaceuticals Inc. | For profit | 1 | 0 | 1 | 2016 |
| Government of China | Government | 1 | 1 | 1 | 2016 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1